Retinal and Choroidal Vascular Disease

Dear Colleagues,

Retinal vascular diseases and choroidal vascular diseases are among the most important eye diseases due to their very important socio-economic impact.

Among the vascular diseases of the retina, diabetic retinopathy and retinal vein occlusions are the two most relevant pathologies in terms of incidence and severity. In fact, diabetic retinopathy is the leading cause of blindness in individuals of working age in industrialized countries.

Among the vascular diseases of the choroid, the two most important pathologies are wet age-related macular degeneration and central serous chorioretinopathy.

Age-related macular degeneration is the leading cause of blindness in individuals over the age of 65. Central serous chorioretinopathy is the 4th cause of maculopathy after diabetic macular edema, macular edema associated with vascular occlusion and age-related macular degeneration.

The aim of this Special Issue is to allow the scientific spread of works concerning the most important ocular pathologies in terms of incidence and severity.

We invite experts to contribute with their original research, whether basic or clinical, on retinal and choroidal vascular disease, to this Special Issue. Authors can also submit review articles describing the evolution of scientific discoveries.

Dr. Francesco Petrillo
Dr. Maria Consiglia Trotta
Dr. Matteo Scaramuzzi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.